Valuation : Medinotec Inc.

Market Cap 58.67M 50.55M 47.86M 43.38M 81.39M 5.6B 81.8M 568M 219M 2.85B 220M 216M 9.01B P/E 2025
27.2x
P/E 2026 74x
Enterprise Value 55.93M 48.19M 45.63M 41.36M 77.59M 5.34B 77.98M 542M 208M 2.72B 210M 205M 8.59B EV / Sales 2025
6,241,228x
EV / Sales 2026 5,748,224x
Free-Float
15.57%
Yield 2025 *
-
Yield 2026 -
3 years 5
Extreme 5
5
5 years 5
Extreme 5
5
10 years 5
Extreme 5
5
Manager TitleAgeSince
Chief Executive Officer 47 2021-04-25
Director of Finance/CFO 40 2021-04-25
Director TitleAgeSince
Chairman 47 -
Director/Board Member 55 2022-06-12
Director/Board Member 69 2022-06-12
Date Insider Type Main position Quantity % Market Cap. Importance
4/16/25 Other

Director

12,073 0.1029%
4/16/25 Other

Director

0 0%
4/16/25 Other

Chief Financial Officer

401,965 3.4257%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-.--% 58.67M
+2.06%-9.10%-29.12%-8.06% 106B
-1.66%-5.22%-29.15%-5.53% 11.47B
-1.84%-5.76%+91.21%+120.15% 9.86B
-1.34%-6.25%-56.39%-72.36% 3.94B
-2.84%-6.11%-30.69%+24.92% 2.33B
+7.16%+15.73%-11.84%-67.34% 2.11B
+1.47%-5.12% - - 1.84B
-2.10%-4.52%-24.89%-31.67% 1.5B
Average +0.10%-2.67%-11.36%-4.99% 15.42B
Weighted average by Cap. +1.32%-7.89%-20.95%-1.07%

Financials

2025 2026
Net sales 9.11 7.85 7.44 6.74 12.64 870.67 12.71 88.31 33.96 442.96 34.23 33.48 1.4K 9.73 8.38 7.94 7.19 13.5 929.51 13.57 94.27 36.25 472.89 36.54 35.74 1.49K
Net income 2.16M 1.86M 1.76M 1.6M 3M 206M 3.01M 20.92M 8.05M 105M 8.11M 7.93M 332M 795K 685K 648K 588K 1.1M 75.9M 1.11M 7.7M 2.96M 38.62M 2.98M 2.92M 122M
Net Debt -1.79M -1.54M -1.46M -1.32M -2.48M -171M -2.49M -17.33M -6.66M -86.94M -6.72M -6.57M -275M -2.74M -2.36M -2.24M -2.03M -3.8M -262M -3.82M -26.56M -10.22M -133M -10.3M -10.07M -421M
Logo Medinotec Inc.
Medinotec Inc., through its primary investment in DISA Medinotec Proprietary Limited, is engaged in medical device manufacturing and distribution. The Company’s segments include Sales Outside the United States and Domestic Sales. The Sales Outside the United States segment includes both internally developed products and third-party products distributed under agreement. The Domestic Sales segment focuses on the proprietary Trachealator product within the United States. The Company manufactures and distributes medical devices that focus on tracheal non-occlusive airway dilatation technology. Its products include Trachealator, Cape Cross PTCA Catheter, Cape Cross Non-Compliant Catheter, Aortic Valve Dilatation Balloon Catheter, and Micro CTO Catheter. The products developed are sold through a network of distributors in many parts of the world and through a direct sales force in South Africa and the United States of America.
Employees
36
  1. Stock Market
  2. Stocks
  3. MDNC Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!